The Quantitative Decision-making Special Interest Group (QDM SIG) was formed in October 2017. It is a group of statisticians from industry and academia, with experience and interests in statistical methods for quantitative decision-making in drug development. The objectives of the SIG are:
| Gianluca Baio (UCL) |
| Nicolas Bonnet (Sanofi) |
| Sarah Bray (Amgen) |
| Alex Carlton (GSK) |
| Jacquie Christie (GSK) |
| Pierre Colin (Debiopharm) |
| Paul Frewer (AstraZeneca) |
| Heiko Goette (Merck) |
| Martin Johnson (UCB Pharma) |
| Kevin Kunzmann (Cambridge University) |
| John-Philip Lawo (CSL Behring) |
| Jesper Madsen (Novo Nordisk) |
| Pavel Mozgunov (Lancaster University) |
| Emmanuel Pham (Ipsen) |
| Veronique Robert (Servier) |
| Oliver Sailer (Boehringer Ingelheim ) |
| Gaëlle Saint-Hilary (Servier) (Chair) |
| Guido Thömmes (Grunenthal) |
For further information, or to join the QDM SIG, please contact the chair:
Gaelle Saint-Hilary (Servier and Politecnico di Torino)
gsainthilary@gmail.com
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
PSI are starting a book club! We will be reading/discussing non-technical books relevant to our roles. Participants will be split into smaller groups to network with each other and practice exercises.
Whatever your current challenge(s) at work, this workshop will explore what's holding you back, and how barriers can be removed in order to progress and achieve.
A PSI Training Course covering the statistical methods for repeated measures and other clustered data. Course will cover: Conditional models for continuous hierarchical data, Conditional models for continuous longitudinal data, Marginal models (GEE) for continuous longitudinal data & Discrete data.
Learn from others in the PSI Community who also associate with Imposter Syndrome. They will discuss the topic, give their own personal views and experiences and provide tips to beat it.
Complex Innovative Designs: overview and case studies from FDA pilot program and considerations on master protocols.
R is quickly gaining popularity within the pharmaceutical industry due to it being a very powerful object-orientated language, and is able to produce analyses and high quality graphics. This will be a hands-on interactive course and will utilise the RStudio Cloud development environment.
In just 1 hour, learn about the field of medical statistics and how it plays a crucial role in developing ground-breaking new medicines, vaccines and healthcare products.
Our annual PSI Medical Statistics Careers Event, will be held online on Wednesday 2nd March 2022. The event will include a live online panel discussion and a virtual exhibition session.
For our global team in Europe we are seeking highly qualified candidates to fill the position of Global Director Biostatistics (m/f/x).
Joining us as Principal Biostatistician you will be responsible for providing statistical support of global clinical development programs in neuroscience.
The Senior Manager Biostatistics will be responsible for leading biostatistics strategy and activities for a compound and/or for individual clinical studies.
Novartis is establishing a virtual Analytics Network in the UK and we are currently recruiting PhD graduates to join this exciting new group!
